Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide
Open Access
- 27 July 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 55 (10), 2741-2746
- https://doi.org/10.1007/s00125-012-2649-3
Abstract
Aims/hypothesis Plasma ceramide concentrations correlate with insulin sensitivity, inflammation and atherosclerotic risk. We hypothesised that plasma ceramide concentrations are increased in the presence of elevated fatty acid levels and are regulated by increased liver serine C-palmitoyltransferase (SPT) activity. Methods Lean humans and rats underwent an acute lipid infusion and plasma ceramide levels were determined. One group of lipid-infused rats was administered myriocin to inhibit SPT activity. Liver SPT activity was determined in lipid-infused rats, and obese, insulin resistant mice. The time and palmitate dose-dependent synthesis of intracellular and secreted ceramide was determined in HepG2 liver cells. Results Plasma ceramide levels were increased during lipid infusion in humans and rats, and in obese, insulin-resistant mice. The increase in plasma ceramide was not associated with changes in liver SPT activity, and inhibiting SPT activity by ∼50% did not alter plasma ceramide levels in lipid-infused rats. In HepG2 liver cells, palmitate incorporation into extracellular ceramide was both dose- and time-dependent, suggesting the liver cells rapidly secreted the newly synthesised ceramide. Conclusions/interpretation Elevated systemic fatty acid availability increased plasma ceramide but this was not associated with changes in hepatic SPT activity, suggesting that liver ceramide synthesis is driven by substrate availability rather than increased SPT activity. This report also provides evidence that the liver is sensitive to the intracellular ceramide concentration, and an increase in liver ceramide secretion may help protect the liver from the deleterious effects of intracellular ceramide accumulation.Keywords
This publication has 15 references indexed in Scilit:
- Pigment Epithelium–Derived Factor Regulates Lipid Metabolism via Adipose Triglyceride LipaseDiabetes, 2011
- Sphingolipids: agents provocateurs in the pathogenesis of insulin resistanceDiabetologia, 2011
- Inhibition of De Novo Ceramide Synthesis Reverses Diet-Induced Insulin Resistance and Enhances Whole-Body Oxygen ConsumptionDiabetes, 2010
- Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart diseaseDiabetologia, 2009
- An improved method to determine serine palmitoyltransferase activityJournal of Lipid Research, 2009
- Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometryJournal of Lipid Research, 2009
- Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin ResistanceDiabetes, 2009
- Inhibition of Ceramide Synthesis Ameliorates Glucocorticoid-, Saturated-Fat-, and Obesity-Induced Insulin ResistanceCell Metabolism, 2007
- Altered Adipose and Plasma Sphingolipid Metabolism in ObesityDiabetes, 2006
- Sphingolipid Biosynthesis de Novo by Rat Hepatocytes in Culture.Journal of Biological Chemistry, 1995